Application of Causal Inference Methods for Analyzing RCT Data Combined With RWD

Author(s)

Farjat A1, Laapas K2, Potts J3
1Bayer PLC, Reading, RDG, UK, 2Bayer Oy (Finland), Espoo, Uusimaa, Finland, 3Bayer Healthcare Pharmaceuticals, LLC, Whippany, NJ, USA

OBJECTIVES: To evaluate treatment effect in a randomized control trial (RCT) using external control arm (ECA) from real-world data (RWD) in the presence of poor balance of baseline characteristics between RCT and ECA.

METHODS: Participants were randomized to one of two experimental arms or an internal control arm (ICA) of a phase II RCT and were evaluated for bleeding events within three months. The Finnish healthcare system was used to develop an anonymized cohort, fulfilling eligibility for the RCT, to use as an ECA. Propensity-score (PS) methods based on 28 known confounders were used to create statistically comparable groups between RCT participants and those eligible from RWD. After PS trimming, inverse probability of treatment weighting (IPTW), G-computation, augmented IPTW (AIPTW), targeted maximum likelihood estimation (TMLE), and overlapping weights (OW) methodologies were applied for comparing the ICA to ECA, and then the treatment effect of the combined ICA+ECA to the RCT experimental arm was evaluated. In addition, a comprehensive Bayesian Dynamic Borrowing approach and the propensity score composite likelihood (PSCL) method were applied.

RESULTS: The RCT had n=505 participants randomized to the experimental arms and n=250 to the ICA. A pool of eligible Finnish RWD (n=3327) was established, of which n=2847 were included after trimming. Although the PS distributions showed poor overlap between the RCT and Finnish ECA subjects, all methods evaluated showed similar results for the proportion of participants experiencing an event. Additionally, from RCT data with augmented control arm (ICA n=250 + ECA n=2847 = 3097 control subjects), the same conclusions can be drawn as the original RCT study.

CONCLUSIONS: Several causal inference methods are available for analyzing RCT data combined with RWD. Many of these methods were applied and showed similar results arriving to the same conclusion in the presence of poor PS distribution overlap.

Conference/Value in Health Info

2024-11, ISPOR Europe 2024, Barcelona, Spain

Value in Health, Volume 27, Issue 12, S2 (December 2024)

Code

RWD76

Topic

Clinical Outcomes, Methodological & Statistical Research, Study Approaches

Topic Subcategory

Clinical Trials, Comparative Effectiveness or Efficacy, Confounding, Selection Bias Correction, Causal Inference, Electronic Medical & Health Records

Disease

Cardiovascular Disorders (including MI, Stroke, Circulatory), No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×